Kvantify Secures €7 Million Funding for Quantum Computing in Drug Development
Aarhus-based Kvantify has completed a €7 million funding round to advance quantum and classical computing for drug development. Investors include the European Innovation Council Fund and Delphinus Venture Capital. The funding will enhance Kvantify's Qrunch technology, aimed at integrating quantum chemistry into practical workflows for pharmaceutical research. The initiative seeks to lower drug development costs and improve the effectiveness of molecular simulations, positioning Europe as a leader in quantum technology.
Theia Market Signal Identification - AI Assisted
Kvantify, a quantum technology scaleup based in Aarhus, has completed a second closing of a €7 million funding round. The investment from the European Innovation Council Fund and Delphinus Venture Capital will accelerate the development of technology that merges quantum and classical computing for drug development.
Kvantify's Qrunch technology, launched in November 2025, allows for quantum chemistry applications on real quantum computers. The company aims to enhance collaboration with drug discovery organizations and strengthen its market position in quantum integration, which could significantly reduce drug development costs and improve outcomes.
Comments